Cargando…

SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period

BACKGROUND: During the current coronavirus disease 2019 (COVID-19) pandemic, many countries require travellers to undergo a reverse transcription-polymerase chain reaction (RT-PCR) testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) before travelling across borders. However, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Srichatrapimuk, Sirawat, Chookajorn, Thanat, Kochakarn, Theerarat, Kirdlarp, Suppachok, Pasomsub, Ekawat, Chantratita, Wasun, Iamsirithaworn, Sopon, Kunakorn, Mongkol, Thitithanyanont, Arunee, Sungkanuparph, Somnuek, Phuphuakrat, Angsana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809637/
https://www.ncbi.nlm.nih.gov/pubmed/35123068
http://dx.doi.org/10.1016/j.tmaid.2022.102271
_version_ 1784644062051041280
author Srichatrapimuk, Sirawat
Chookajorn, Thanat
Kochakarn, Theerarat
Kirdlarp, Suppachok
Pasomsub, Ekawat
Chantratita, Wasun
Iamsirithaworn, Sopon
Kunakorn, Mongkol
Thitithanyanont, Arunee
Sungkanuparph, Somnuek
Phuphuakrat, Angsana
author_facet Srichatrapimuk, Sirawat
Chookajorn, Thanat
Kochakarn, Theerarat
Kirdlarp, Suppachok
Pasomsub, Ekawat
Chantratita, Wasun
Iamsirithaworn, Sopon
Kunakorn, Mongkol
Thitithanyanont, Arunee
Sungkanuparph, Somnuek
Phuphuakrat, Angsana
author_sort Srichatrapimuk, Sirawat
collection PubMed
description BACKGROUND: During the current coronavirus disease 2019 (COVID-19) pandemic, many countries require travellers to undergo a reverse transcription-polymerase chain reaction (RT-PCR) testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) before travelling across borders. However, in persons having recovered from COVID-19, RT-PCR positivity can persist for an extended period. MATERIALS AND METHODS: We describe three cases who sought fit-to-fly certificates in Thailand during the period free of local transmission but were tested positive for RT-PCR for SARS-CoV-2. All had returned from a country with an active outbreak of COVID-19. Their clinical courses are described; positive nasopharyngeal swab samples were processed for viral isolation and whole-genome sequencing (WGS); and serology as well as neutralizing antibody were assessed. The contact tracing was carried out for determining evidence of indigenous transmission among close contacts of those three cases. RESULTS: All three cases were completely asymptomatic. Chest computerized tomography was not compatible with COVID-19 pneumonia; cell cultures failed to rescue replication-competent virus; WGS revealed fragmented viral genetic material from nasopharyngeal swab samples; and serological tests demonstrated stable levels of antibodies, together with the presence of neutralizing antibody, suggesting past infection with negligible transmission risk. Contact tracing identified no transmission in high-risk close contact individuals. CONCLUSION: RT-PCR positivity for SARS-CoV-2 might detect fragmented viral genome. Issuance of a travel certificate in these circumstances is problematic. Serology tests can help to define past infection. A practical acceptable set of guidelines for issuance of a COVID-19 safety travel certification is a necessity.
format Online
Article
Text
id pubmed-8809637
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88096372022-02-03 SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period Srichatrapimuk, Sirawat Chookajorn, Thanat Kochakarn, Theerarat Kirdlarp, Suppachok Pasomsub, Ekawat Chantratita, Wasun Iamsirithaworn, Sopon Kunakorn, Mongkol Thitithanyanont, Arunee Sungkanuparph, Somnuek Phuphuakrat, Angsana Travel Med Infect Dis Article BACKGROUND: During the current coronavirus disease 2019 (COVID-19) pandemic, many countries require travellers to undergo a reverse transcription-polymerase chain reaction (RT-PCR) testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) before travelling across borders. However, in persons having recovered from COVID-19, RT-PCR positivity can persist for an extended period. MATERIALS AND METHODS: We describe three cases who sought fit-to-fly certificates in Thailand during the period free of local transmission but were tested positive for RT-PCR for SARS-CoV-2. All had returned from a country with an active outbreak of COVID-19. Their clinical courses are described; positive nasopharyngeal swab samples were processed for viral isolation and whole-genome sequencing (WGS); and serology as well as neutralizing antibody were assessed. The contact tracing was carried out for determining evidence of indigenous transmission among close contacts of those three cases. RESULTS: All three cases were completely asymptomatic. Chest computerized tomography was not compatible with COVID-19 pneumonia; cell cultures failed to rescue replication-competent virus; WGS revealed fragmented viral genetic material from nasopharyngeal swab samples; and serological tests demonstrated stable levels of antibodies, together with the presence of neutralizing antibody, suggesting past infection with negligible transmission risk. Contact tracing identified no transmission in high-risk close contact individuals. CONCLUSION: RT-PCR positivity for SARS-CoV-2 might detect fragmented viral genome. Issuance of a travel certificate in these circumstances is problematic. Serology tests can help to define past infection. A practical acceptable set of guidelines for issuance of a COVID-19 safety travel certification is a necessity. Elsevier Ltd. 2022 2022-02-02 /pmc/articles/PMC8809637/ /pubmed/35123068 http://dx.doi.org/10.1016/j.tmaid.2022.102271 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Srichatrapimuk, Sirawat
Chookajorn, Thanat
Kochakarn, Theerarat
Kirdlarp, Suppachok
Pasomsub, Ekawat
Chantratita, Wasun
Iamsirithaworn, Sopon
Kunakorn, Mongkol
Thitithanyanont, Arunee
Sungkanuparph, Somnuek
Phuphuakrat, Angsana
SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period
title SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period
title_full SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period
title_fullStr SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period
title_full_unstemmed SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period
title_short SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period
title_sort sars-cov-2 rt-pcr positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809637/
https://www.ncbi.nlm.nih.gov/pubmed/35123068
http://dx.doi.org/10.1016/j.tmaid.2022.102271
work_keys_str_mv AT srichatrapimuksirawat sarscov2rtpcrpositivityofindividualssubsequenttocompletingquarantineuponentryintoacountryduringatransmissionfreeperiod
AT chookajornthanat sarscov2rtpcrpositivityofindividualssubsequenttocompletingquarantineuponentryintoacountryduringatransmissionfreeperiod
AT kochakarntheerarat sarscov2rtpcrpositivityofindividualssubsequenttocompletingquarantineuponentryintoacountryduringatransmissionfreeperiod
AT kirdlarpsuppachok sarscov2rtpcrpositivityofindividualssubsequenttocompletingquarantineuponentryintoacountryduringatransmissionfreeperiod
AT pasomsubekawat sarscov2rtpcrpositivityofindividualssubsequenttocompletingquarantineuponentryintoacountryduringatransmissionfreeperiod
AT chantratitawasun sarscov2rtpcrpositivityofindividualssubsequenttocompletingquarantineuponentryintoacountryduringatransmissionfreeperiod
AT iamsirithawornsopon sarscov2rtpcrpositivityofindividualssubsequenttocompletingquarantineuponentryintoacountryduringatransmissionfreeperiod
AT kunakornmongkol sarscov2rtpcrpositivityofindividualssubsequenttocompletingquarantineuponentryintoacountryduringatransmissionfreeperiod
AT thitithanyanontarunee sarscov2rtpcrpositivityofindividualssubsequenttocompletingquarantineuponentryintoacountryduringatransmissionfreeperiod
AT sungkanuparphsomnuek sarscov2rtpcrpositivityofindividualssubsequenttocompletingquarantineuponentryintoacountryduringatransmissionfreeperiod
AT phuphuakratangsana sarscov2rtpcrpositivityofindividualssubsequenttocompletingquarantineuponentryintoacountryduringatransmissionfreeperiod